Post #1572 by jerryab on the Macroeconomic Trends and Risks board

Personal Finance Topics / Macroeconomic Trends and Risks ❤

Unthreaded | Threaded | Whole Thread (3)

Post Reply | Report Post | Recommend It!

No. of Recommendations: 1

https://www.theguardian.com/society/2025/aug/30/dr...

High blood pressure is a problem for many people. New drug helps with people who can not manage with previous drugs.

Print the post

Post Reply | Report Post | Recommend It!

No. of Recommendations: 0

From the linked article"

About four in 10 patients taking the drug – 1mg (39.4%) or 2mg (40%) once daily in tablet form – reached healthy blood pressure levels, compared with fewer than two in 10 (18.7%) on placebo.

What happened to the other 4 in 10? Did they die? Did they drop out of the study because of side effects? Did the missing 4 in 10 match the placebo group?

Print the post

Post Reply | Report Post | Recommend It!

No. of Recommendations: 3

What happened to the other 4 in 10?

Can't say specifically, but some (many?) were in the placebo group. You also missed a key point. The entire group was comprised of people who got little or or help from existing drugs. So a 40% success rate is fantastic with that group. When the placebo group gets the real drug, it will likely push the success rate near to or over 60%.

Print the post

Post New

Unthreaded | Threaded | Whole Thread (3)

Prev | Next

Announcements

Macroeconomic Trends and Risks FAQ

Contact Shrewd'm
Contact the developer of these message boards.

A community forum supporting civilized, and highly helpful, self-educating investors that come together for Shrewdness and merry spirits. These message boards closely follow the look and feel of the old message boards at boards.fool.com prior to the boards redirected to discussion.fool.com. Shrewd'm is not affiliated with the comprehensive and excellent investment website, The Motley Fool (TMF), in any way. The Shrewd commmunity here has owed, and continues to owe, gratitude to The Motley Fool for nurturing a culture of jovial irreverence towards Wall St, and that tradition will continue here.